A GPCR-based yeast biosensor for biomedical, biotechnological, and point-of-use cannabinoid determination

Karel Miettinen,Nattawat Leelahakorn,Aldo Almeida,Yong Zhao,Lukas R. Hansen,Iben E. Nikolajsen,Jens B. Andersen,Michael Givskov,Dan Staerk,Søren Bak,Sotirios C. Kampranis

DOI: https://doi.org/10.1038/s41467-022-31357-6

IF: 16.6

2022-06-27

Nature Communications

Abstract:Abstract Eukaryotic cells use G-protein coupled receptors to sense diverse signals, ranging from chemical compounds to light. Here, we exploit the remarkable sensing capacity of G-protein coupled receptors to construct yeast-based biosensors for real-life applications. To establish proof-of-concept, we focus on cannabinoids because of their neuromodulatory and immunomodulatory activities. We construct a CB 2 receptor-based biosensor, optimize it to achieve high sensitivity and dynamic range, and prove its effectiveness in three applications of increasing difficulty. First, we screen a compound library to discover agonists and antagonists. Second, we analyze 54 plants to discover a new phytocannabinoid, dugesialactone. Finally, we develop a robust portable device, analyze body-fluid samples, and confidently detect designer drugs like JWH-018. These examples demonstrate the potential of yeast-based biosensors to enable diverse applications that can be implemented by non-specialists. Taking advantage of the extensive sensing repertoire of G-protein coupled receptors, this technology can be extended to detect numerous compounds.

multidisciplinary sciences